Newborn Screening
Use of residual dried blood spots from newborn screening programs is examined
Published in Medical Letter on the CDC and FDA, July 30th, 2006
Researchers in the United States conducted a study "to provide current data for policy discussions and to assess future needs among newborn screening programs regarding the storage and use of residual dried blood spots (DBS) in the United States."
"An electronic questionnaire was administered to U.S. state health department laboratory directors in 2003. Responses were received from 49 of the 50 states. Approximately half of them stored residual DBS for more than six months, 57% did not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food Poisoning
U.S. FDA issues guidance to help prevent introduction of allergens or toxins into food and feed - Pneumonia Risk Factors
Severe pneumonia due to Staphylococcus aureus was linked to methicillin-resistance - Proteomics
Epstein-Barr virus nuclear antigen 2 induces Fc-receptor homolog 5 expression through CBF1 protein - Public Health
Violence against women is more likely during pregnancy than after delivery - Addiction Medicine
Assessment method affects dosage estimate in recreational ecstasy users - Addiction Medicine
New drug application submitted for studies of subdermal implant for treating opioid addiction - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
